Benefits and Harms of Once-weekly Glucagon-like peptide-1 receptor agonist treatments. A systematic review and network meta-analysis
journal contribution
posted on 2015-10-27, 15:57authored byMelanie J. Davies, Francesco Zaccardi, Zin Zin Htike, David R. Webb, Kamlesh Khunti
Benefits and Harms of Once-weekly Glucagon-like peptide-1 receptor agonist treatments. A systematic review and network meta-analysis
History
Citation
Annals of Internal Medicine, 2015, in press
Author affiliation
/Organisation/COLLEGE OF MEDICINE, BIOLOGICAL SCIENCES AND PSYCHOLOGY/School of Medicine/Department of Cardiovascular Sciences
Version
AM (Accepted Manuscript)
Published in
Annals of Internal Medicine
Publisher
American College of Physicians
issn
0003-4819
eissn
1539-3704
Acceptance date
2015-10-19
Copyright date
2015
Publisher version
http://annals.org/
Notes
The file associated with this record is under permanent embargo due to the publishers archiving policy. It may be available from PubMed Central 6 months after publication.